Nyxoah
Belgium - Mont-Saint-GuibertMedical Devices
Focus: Nyxoah is a Belgium-based medical device company focused on implantable neurostimulation technology for sleep apnea treatment. The company represents a niche player in the sleep disorders device market.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About Nyxoah
AI assessmentNot HiringNo open roles listed right now. Follow Nyxoah to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
8 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Genio® system therapy
Obstructive Sleep ApneaClinical Trials (1)
NCT04031040A Post-market Clinical Follow up of the Genio® System for the Treatment of Obstructive Sleep Apnea in Adults
N/AHelp build intelligence for Nyxoah
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.